Best Medication for Anxiety: SSRIs, SNRIs, and Other Options
Several classes of medication effectively treat anxiety disorders. This guide covers all major options — from first-line SSRIs to adjunctive treatments — with comparison tables to help you understand your choices before talking to your doctor.
Medication is one part of treatment. Research shows that combining medication with cognitive behavioral therapy (CBT) produces the best outcomes for most anxiety disorders. Medication can reduce symptoms enough to engage in therapy effectively.
Medication Classes at a Glance
| Class | Examples | Onset | Use | Dependence Risk |
|---|---|---|---|---|
| SSRIs | Sertraline, Escitalopram, Paroxetine, Fluoxetine | 2–6 weeks | First-line for all anxiety disorders | None |
| SNRIs | Venlafaxine, Duloxetine | 2–6 weeks | First-line; esp. with co-occurring pain | None |
| Buspirone | Buspirone (BuSpar) | 2–4 weeks | GAD specifically | None |
| Benzodiazepines | Alprazolam, Lorazepam, Clonazepam | 30–60 min | Short-term/acute only | High |
| Beta-Blockers | Propranolol, Atenolol | 30–60 min | Performance anxiety, physical symptoms | None |
| Antihistamines | Hydroxyzine | 30–60 min | Short-term/as-needed anxiety | None |
| Pregabalin | Lyrica | 1–2 weeks | GAD (approved in EU, off-label in US) | Low-moderate |
First-Line Medications
SSRIs — Selective Serotonin Reuptake Inhibitors
SSRIs are the most prescribed and most studied medications for anxiety. They increase serotonin availability in the brain by blocking its reabsorption.
| Medication | Brand | Dose Range | FDA Anxiety Indications | Notable |
|---|---|---|---|---|
| Sertraline | Zoloft | 50–200 mg | Panic, PTSD, Social Anxiety, OCD | Most FDA indications; preferred in pregnancy |
| Escitalopram | Lexapro | 10–20 mg | GAD | Most selective SSRI; fewest drug interactions |
| Paroxetine | Paxil | 20–60 mg | GAD, Panic, Social Anxiety, OCD | Most anticholinergic; harder to discontinue |
| Fluoxetine | Prozac | 20–80 mg | Panic, OCD | Longest half-life; easiest to taper |
| Fluvoxamine | Luvox | 100–300 mg | OCD, Social Anxiety | Primarily used for OCD |
Common side effects: Nausea (usually transient, 1–2 weeks), sexual dysfunction (reduced libido, delayed orgasm — most persistent side effect), insomnia or drowsiness, headache, weight changes. Starting at a low dose and increasing gradually minimizes initial side effects.
Timeline: Initial improvement at 2–4 weeks. Full therapeutic effect at 6–12 weeks. If no response after 8 weeks at adequate dose, consider switching or augmenting.
SNRIs — Serotonin-Norepinephrine Reuptake Inhibitors
SNRIs block reabsorption of both serotonin and norepinephrine. They're equally effective as SSRIs for anxiety and may be preferred when anxiety co-occurs with chronic pain or fatigue.
| Medication | Brand | Dose Range | FDA Anxiety Indications | Notable |
|---|---|---|---|---|
| Venlafaxine XR | Effexor XR | 75–225 mg | GAD, Social Anxiety, Panic | Broad indications; BP monitoring needed at high doses |
| Duloxetine | Cymbalta | 60–120 mg | GAD | Also treats chronic pain; fibromyalgia |
Additional side effects vs SSRIs: Blood pressure elevation (especially venlafaxine >225 mg), increased sweating, and potentially more pronounced discontinuation syndrome. Always taper gradually.
Buspirone
Buspirone is a unique anxiolytic that works as a serotonin 5-HT1A partial agonist. It's FDA-approved specifically for GAD and has several advantages:
- No sedation or cognitive impairment
- No dependence or withdrawal risk
- No sexual dysfunction
- No interaction with alcohol
Limitations: Only effective for GAD (not panic disorder, social anxiety, or OCD). Takes 2–4 weeks to work. Must be taken consistently — doesn't work on an as-needed basis. Typical dose: 15–60 mg/day in divided doses. Can be combined with SSRIs.
Second-Line and Adjunctive Options
Benzodiazepines
Benzodiazepines enhance GABA activity in the brain, producing rapid anxiolytic, sedative, and muscle relaxant effects. They work within 30–60 minutes — making them useful for acute crises.
| Medication | Brand | Onset | Duration | Common Use |
|---|---|---|---|---|
| Alprazolam | Xanax | 15–30 min | 4–6 hours | Panic attacks (rapid onset) |
| Lorazepam | Ativan | 20–30 min | 6–8 hours | Acute anxiety, pre-procedure |
| Clonazepam | Klonopin | 30–60 min | 8–12 hours | GAD, panic (longer-acting) |
| Diazepam | Valium | 15–30 min | 12–24 hours | Muscle relaxation, acute anxiety |
⚠️ Dependence warning: Physical dependence can develop within 2–4 weeks of daily use. Current APA guidelines recommend benzodiazepines only for short-term use (2–4 weeks) or as a bridge while SSRIs/SNRIs take effect. Abrupt discontinuation can cause seizures. Always taper under medical supervision.
Beta-Blockers
Propranolol (10–40 mg) blocks the physical symptoms of anxiety — rapid heartbeat, trembling, sweating — without affecting cognitive or emotional symptoms. Primarily used for:
- Performance anxiety: Public speaking, presentations, auditions
- Situational anxiety: Specific predictable stressors
Taken 30–60 minutes before the stressful event. Not effective for generalized or chronic anxiety. Not habit-forming. Contraindicated in asthma.
Hydroxyzine
An antihistamine with anxiolytic properties. Hydroxyzine (Vistaril/Atarax) works within 30–60 minutes and can be used as-needed. No dependence risk. Main side effect is drowsiness, which limits daytime use. Typical dose: 25–100 mg. Often used as a benzodiazepine alternative for patients with substance use history.
Pregabalin (Lyrica)
Pregabalin modulates calcium channels and is approved for GAD treatment in the European Union (used off-label in the US). It works within 1–2 weeks — faster than SSRIs — and may be particularly useful for anxiety with insomnia. Dose: 150–600 mg/day. Some abuse potential exists; it's a Schedule V controlled substance in the US.
How to Choose the Right Medication
Your doctor will consider these factors:
- Anxiety disorder type: GAD, panic, social anxiety, and OCD each have medications with the strongest evidence
- Co-occurring conditions: Depression favors SSRIs/SNRIs; chronic pain favors duloxetine; insomnia may favor hydroxyzine or pregabalin
- Side effect concerns: Sexual dysfunction concern → consider buspirone; GI sensitivity → consider escitalopram; weight concern → consider sertraline
- Other medications: Drug interactions matter — escitalopram has the fewest
- Previous response: What's worked or failed before is highly informative
- Cost and access: Generic SSRIs are $4–15/month; brand medications can cost hundreds
Starting medication: Most people try 1–2 medications before finding the right fit. Starting at a low dose, increasing gradually, and giving each medication a full 8-week trial is important. Don't give up if the first one doesn't work — the right medication is out there.
What to Expect When Starting
Week 1–2: Side effects are most noticeable (nausea, headache, increased anxiety). These usually resolve. Your doctor may start you at half the target dose.
Week 2–4: Initial improvement. You may notice you're slightly less on-edge, sleeping better, or worrying less intensely.
Week 6–12: Full therapeutic effect. This is when you can truly evaluate whether the medication is working. Most clinicians recommend waiting 8 weeks at an adequate dose before switching.
Long-term: Guidelines recommend continuing for at least 12 months after remission. Stopping too early is the most common cause of relapse. When you and your doctor decide to stop, always taper gradually over weeks to months.
Frequently Asked Questions
Related Articles
Lexapro vs Zoloft: Head-to-Head Comparison → Best Treatment for Anxiety: Therapy, Meds, and More → CBD for Anxiety: What the Research Shows → How to Stop a Panic Attack →Sources
- Bandelow B, et al. "Efficacy of treatments for anxiety disorders: a meta-analysis." International Clinical Psychopharmacology. 2015;30(4):183-192. PubMed
- Slee A, et al. "Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis." The Lancet. 2019;393(10173):768-777. PubMed
- Cipriani A, et al. "Comparative efficacy and acceptability of 12 new-generation antidepressants." The Lancet. 2009;373(9665):746-758. PubMed
- Baldwin DS, et al. "Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder." International Journal of Neuropsychopharmacology. 2014;17(3):405-425. PubMed
- Strawn JR, et al. "Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients." Expert Opinion on Pharmacotherapy. 2018;19(10):1057-1070. PubMed
- National Institute of Mental Health. "Anxiety Disorders." NIMH
- Mayo Clinic. "Anxiety disorders — Diagnosis and treatment." Mayo Clinic